Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial
在一项二期临床试验中,对狼疮性肾炎患者进行代谢组学分析发现,阿尼弗鲁单抗治疗可通过抑制I型干扰素来调节独特的代谢物。
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2025-005932
Gavin, Patrick G; Allman, Erik L; Jayne, David; Mysler, Eduardo; Amoura, Zahir; Di Poto, Cristina; Tian, Xiang; Hess, Sonja; Csomor, Eszter; Brohawn, Philip Z; Muthas, Daniel; Platt, Adam; Anzillotti, Consuelo; Stone, Heena; Seth, Asha; Woollard, Kevin; Al-Mossawi, Hussein; Lindholm, Catharina; Ferrari, Nicola